tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NRXP Stock Latest News

NRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
TipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
3d ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
11d ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
19d ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic
23d ago
NRXP
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
PremiumThe Fly
Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial
23d ago
CMND
CMPS
NRx Pharmaceuticals and subsidiary to acquire interest in Cohen clinic, Florida
PremiumThe FlyNRx Pharmaceuticals and subsidiary to acquire interest in Cohen clinic, Florida
23d ago
NRXP
NRx Pharmaceuticals announces filing for FDC’s NPV program on behalf of NRX-100
Premium
The Fly
NRx Pharmaceuticals announces filing for FDC’s NPV program on behalf of NRX-100
26d ago
NRXP
NRx Pharmaceuticals files $150M mixed securities shelf
Premium
The Fly
NRx Pharmaceuticals files $150M mixed securities shelf
29d ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
1M ago
NRXP
NRX Pharmaceuticals Submits FDA Application for NRX-100
PremiumCompany Announcements
NRX Pharmaceuticals Submits FDA Application for NRX-100
1M ago
8K
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
1M ago
NRXP
NRX Pharmaceuticals: Strategic Positioning and Market Potential Drive Buy Rating
PremiumRatings
NRX Pharmaceuticals: Strategic Positioning and Market Potential Drive Buy Rating
1M ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine
1M ago
NRXP
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
Premium
The Fly
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
1M ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
2M ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition
2M ago
NRXP
NRX Pharmaceuticals Announces $7.8M Debt Financing Deal
PremiumCompany Announcements
NRX Pharmaceuticals Announces $7.8M Debt Financing Deal
2M ago
8K
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21
PremiumTipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21
2M ago
NRXP
Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
PremiumTipRanks Newswire
Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
2M ago
NRXP
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup 
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup 
2M ago
NRXP
NRx Pharmaceuticals Earnings Call Highlights Progress and Optimism
Premium
Company Announcements
NRx Pharmaceuticals Earnings Call Highlights Progress and Optimism
2M ago
NRXP
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook
Premium
Ratings
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook
2M ago
NRXP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >